Nvidia earnings next week will be another validation moment for the chipmaker, says Dan Ives, the global head of tech ...

Matt Bryson, Wedbush, joins 'Closing Bell Overtime' to talk why he decided to raise Nvidia's price target and what he expects ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

A consensus of analysts expects Nvidia (NASDAQ:NVDA) to report about $1.01 in earnings per share on roughly $45.92 billi ...

Oklo Inc. (NYSE:OKLO) is one of the best Russell 2000 stocks to buy now. On August 14, Wedbush reiterated its “Outperform” ...

The IVES AI 30 list is a group of 30 tech companies analysts led by Daniel Ives believe will define the future of the AI ...

Nvidia's (NVDA) upcoming quarterly results on August 27 are likely to be another “positive catalyst” for investors, Wedbush ...

Detailed price information for Biocryst Pharma Inc (BCRX-Q) from The Globe and Mail including charting and trades.

Wedbush has lifted its price target on Palantir Technologies (NASDAQ:PLTR) from $160 to a Street high of $200 per share in a note Tuesday, citing surging demand for its artificial intelligence (AI) ...

The 21-story tower at 1000 Wilshire Boulevard was appraised at $60.5 million, 69 percent below its $197.5 million at issuance ...

Downtown's Wedbush Center has lost about 69% of its value in seven years, according to an August appraisal. The 21-story ...

In a note to investors Tuesday, Daniel Ives, managing director and senior equity research analyst at Wedbush Securities, wrote that a Palo Alto Networks-CyberArk combination would be a ...